Biocon Ltd Financials
Company Logo

Biocon Ltd Financial Statement

Biocon Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2025
Revenue706.50
Operating Expense581.80
Net Profit21.20
Net Profit Margin3.00
Earning Per Share0.18
EBIDTA137.40
Effective Tax Rate21.25

Biocon Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual2,127.30
Operating Expenses Annual1,864.60
Operating Profit Annual470.20
Interest Annual198.80
Depreciation114.10
Net Profit Annual119.30
Tax Annual31

Biocon Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning196.60
Cash Flow from Operations-123.20
Cash Flow from Investing-294.70
Cash Flow from Financing343.60
Cash Flow at the End122.30

Biocon Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)21.31
PBIT Margin (%)15.62
PBT Margin (%)15.54
Net PROFIT Margin (%)5.61
Return On Networth / Equity (%)0.97
Return On Networth /Employed (%)2.61
Return On Assets (%)0.95
Total Debt / Equity (X)0.15
Asset Turnover Ratio (%)0.17

Biocon Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual915
Total Current Assets Annual2,760
Non Current Assets Annual11,008.20
Total Shareholders Funds Annual10,912.30
Total Assets Annual13,768.20

Biocon Ltd Earning Calls

EPS (INR)

Expected

2.87

Reported

2.88

Surprise

0.35%

Dec 2024

EPS beaten by 0.35%

Sep 2024

EPS beaten by 0.00%

Jun 2024

EPS beaten by 0.00%

FAQS on Biocon Ltd Financials

As of Jun 6, 2025, Biocon Ltd has a market capitalization of 40,964.47 Cr. Value Research classifies it as a Large-Cap company.

Yes, Biocon Ltd is with a debt-to-equity ratio of 0.25.

In FY 2024 , Biocon Ltd recorded a total revenue of approximately 2,242.60 Cr marking a significant milestone in the company's financial performance.

Biocon Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.3% and 0.1% annually, respectively..

Biocon Ltd's current PE ratio is 67.23.

Biocon Ltd's ROCE averaged 2.0% from the FY ending March 2023 to 2025, with a median of 2.0%. It peaked at 2.7% in March 2024, reflecting strong capital efficiency over the period..

Biocon Ltd's latest EBIT is Rs. 897.80 Cr, surpassing the average EBIT of Rs. 1,429.23 Cr over the 5 years..

Join the Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions